siRNA therapy reduces triglycerides in patients along with unusual problem

.STUDY FEATURE.19 September 2024.

Plozasiran reduced triglyceride amounts through 80% and lowered the danger of pancreatitis in patients along with consistent chylomicronemia, with or without a genetic medical diagnosis.